UK multicentre real-world study demonstrates a sharp increase in diabetic macular oedema following cataract surgery
Research conducted on behalf of the UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group has shown that the rate of developing “treatment-requiring” diabetic macular oedema (DMO), following cataract surgery, increases dramatically, peaking in the 3-6 months’ postoperative period. In addition, the research demonstrated that patients with moderate and severe non-proliferative diabetic retinopathy (NPDR) […]Read full story
NEI sponsored “Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)” demonstrates equivalence between Avastin and Eylea in CRVO
Clinical research, funded by the US National Eye Institute (NEI), and led by a broad consortium of ophthalmology experts at 66 clinical / academic sites across the US, has concluded that, in terms of visual acuity after 6 months, treatment of central retinal or hemi-retinal vein occlusion (CRVO / HRVO) with bevacizumab (Avastin) is non-inferior […]Read full story
New screening algorithm for diabetic retinopathy progression may save $1 billion over 20 years according to research consortium.
Researchers from the Diabetes Control and Complications Trial (DCCT), and the Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, have published comprehensive findings indicating that individualized retinal screening could save significant resources by reducing the frequency of eye exams without delaying diagnosis. The research, published in the New England Journal of Medicine (N Engl […]Read full story